Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Cervical Cancer

  Free Subscription


1 Adv Clin Chem
1 Asian J Surg
3 Asian Pac J Cancer Prev
1 Biochem Biophys Res Commun
1 Biomed Pharmacother
1 Biosci Rep
2 BMC Infect Dis
1 BMJ Open
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Manag Res
1 Cancers (Basel)
1 Cell Death Dis
1 DNA Cell Biol
1 Front Oncol
1 Front Pharmacol
1 Fundam Clin Pharmacol
1 Gen Thorac Cardiovasc Surg
1 Gynecol Endocrinol
1 Gynecol Obstet Invest
3 Gynecol Oncol
1 Health Psychol Rev
1 HIV Med
1 Int J Cancer
2 Int J Gynaecol Obstet
3 Int J Gynecol Cancer
1 Int J Health Geogr
1 Iran J Public Health
1 J Biomol Struct Dyn
1 J Cancer Res Clin Oncol
2 J Comput Assist Tomogr
1 J Infect Dis
1 Lancet Infect Dis
1 Medicine (Baltimore)
1 Pract Radiat Oncol
1 Semin Radiat Oncol
1 Turk J Pharm Sci
1 Zhonghua Fu Chan Ke Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Adv Clin Chem

  1. ZHOU YH, Cui YH, Wang T, Luo Y, et al
    Long non-coding RNA HOTAIR in cervical cancer: Molecular marker, mechanistic insight, and therapeutic target.
    Adv Clin Chem. 2020;97:117-140.
    PubMed         Abstract available

    Asian J Surg

  2. KIM S, Min KJ, Lee S, Hong JH, et al
    Learning curve could affect oncologic outcome of minimally invasive radical hysterectomy for cervical cancer.
    Asian J Surg. 2020 May 25. pii: S1015-9584(20)30135.
    PubMed         Abstract available

    Asian Pac J Cancer Prev

  3. ZHAO F, Wen Y, Li Y, Tao S, et al
    Epidemiologic and Health Economic Evaluation of Cervical Cancer Screening in Rural China.
    Asian Pac J Cancer Prev. 2020;21:1317-1325.
    PubMed         Abstract available

  4. KARIMI-ZARCHI M, Abbasi H, Javaheri A, Hadadan A, et al
    Association of IL-12B rs3212227 and IL-6 rs1800795 Polymorphisms with Susceptibility to Cervical Cancer: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2020;21:1197-1206.
    PubMed         Abstract available

  5. ADEBAYO IA, Arsad H, Gagman HA, Ismail NZ, et al
    Inhibitory Effect of Eco-Friendly Naturally Synthesized Silver Nanoparticles from the Leaf Extract of Medicinal Detarium microcarpum Plant on Pancreatic and Cervical Cancer Cells.
    Asian Pac J Cancer Prev. 2020;21:1247-1252.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  6. ZHANG R, Li L, Chen L, Suo Y, et al
    MAP7 interacts with RC3H1 and cooperatively regulate cell-cycle progression of cervical cancer cells via activating the NF-kappaB signaling.
    Biochem Biophys Res Commun. 2020;527:56-63.
    PubMed         Abstract available

    Biomed Pharmacother

  7. GUO Q, Li L, Bo Q, Chen L, et al
    Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis.
    Biomed Pharmacother. 2020;128:110072.
    PubMed         Abstract available

    Biosci Rep

  8. LIU D, Huang K, Wang T, Zhang X, et al
    NR2F2-AS1 accelerates cell proliferation through regulating miR-4429/MBD1 axis in cervical cancer.
    Biosci Rep. 2020 May 29. pii: 225078. doi: 10.1042/BSR20194282.
    PubMed         Abstract available

    BMC Infect Dis

  9. REUSCHENBACH M, Mihm S, Wolle R, Schneider KM, et al
    Burden of HPV related anogenital diseases in young women in Germany - an analysis of German statutory health insurance claims data from 2012 to 2017.
    BMC Infect Dis. 2020;20:297.
    PubMed         Abstract available

  10. BOLATTI EM, Hosnjak L, Chouhy D, Casal PE, et al
    Assessing Gammapapillomavirus infections of mucosal epithelia with two broad-spectrum PCR protocols.
    BMC Infect Dis. 2020;20:274.
    PubMed         Abstract available

    BMJ Open

  11. ALMONTE M, Murillo R, Sanchez GI, Gonzalez P, et al
    Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol.
    BMJ Open. 2020;10:e035796.
    PubMed         Abstract available

    Cancer Epidemiol Biomarkers Prev

  12. BIDDELL CB, O'leary M, Wheeler SB, Spees LP, et al
    Variation in Cervical Cancer Screening Preferences Among Medically Underserved Individuals in the US: A Systematic Review.
    Cancer Epidemiol Biomarkers Prev. 2020 May 26. pii: 1055-9965.EPI-20-0306.
    PubMed         Abstract available

    Cancer Manag Res

  13. Erratum: Selective Use of Concurrent Chemotherapy in Elderly Cervical Cancer Patients Treated with Definitive Radiotherapy: Experience from Two Institutions [Erratum].
    Cancer Manag Res. 2020;12:3079.
    PubMed         Abstract available

    Cancers (Basel)

  14. AYEN A, Jimenez Martinez Y, Boulaiz H
    Targeted Gene Delivery Therapies for Cervical Cancer.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available

    Cell Death Dis

  15. LI X, Ma N, Zhang Y, Wei H, et al
    Circular RNA circNRIP1 promotes migration and invasion in cervical cancer by sponging miR-629-3p and regulating the PTP4A1/ERK1/2 pathway.
    Cell Death Dis. 2020;11:399.
    PubMed         Abstract available

    DNA Cell Biol

  16. LIU J, Yang J, Gao F, Li S, et al
    A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
    DNA Cell Biol. 2020 May 22. doi: 10.1089/dna.2020.5590.
    PubMed         Abstract available

    Front Oncol

  17. LUCIA F, Miranda O, Abgral R, Bourbonne V, et al
    Use of Baseline (18) F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer.
    Front Oncol. 2020;10:678.
    PubMed         Abstract available

    Front Pharmacol

  18. CHEN S, Gao C, Wu Y, Huang Z, et al
    Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.
    Front Pharmacol. 2020;11:544.
    PubMed         Abstract available

    Fundam Clin Pharmacol

  19. LIU Y, Zhao R, Fang S, Li Q, et al
    Abemaciclib sensitizes HPV-negative cervical cancer to chemotherapy via specifically suppressing CDK4/6-Rb-E2F and mTOR pathways.
    Fundam Clin Pharmacol. 2020 May 23. doi: 10.1111/fcp.12574.
    PubMed         Abstract available

    Gen Thorac Cardiovasc Surg

  20. IIJIMA Y, Kinoshita H, Nakajima Y, Kurihara Y, et al
    Accessory diaphragm associated with pulmonary metastasis from cervical cancer.
    Gen Thorac Cardiovasc Surg. 2020 May 21. pii: 10.1007/s11748-020-01380.
    PubMed         Abstract available

    Gynecol Endocrinol

  21. ZHANG J, Liu B, Zhang P, Wang L, et al
    Knockdown of SNHG1 inhibits cervical cancer growth through sponging miR-194 to regulate HCCR.
    Gynecol Endocrinol. 2020 May 27:1-7. doi: 10.1080/09513590.2020.1770722.
    PubMed         Abstract available

    Gynecol Obstet Invest

  22. SHI R, Xu L, Huang L, Cheng JX, et al
    Nucleoporin 107 Promotes the Survival of Tumor Cells in Cervical Cancers.
    Gynecol Obstet Invest. 2020;85:41-52.
    PubMed         Abstract available

    Gynecol Oncol

  23. DIAZ-FEIJOO B, Franco S, Torne A, Benito V, et al
    Implications of extraperitoneal paraaortic lymphadenectomy to the left renal vein in locally advanced cervical cancer. A Spanish multicenter study.
    Gynecol Oncol. 2020 May 26. pii: S0090-8258(20)31071.
    PubMed         Abstract available

  24. HE F, Li W, Liu P, Kang S, et al
    Influence of uterine corpus invasion on prognosis in stage IA2-IIB cervical cancer: A multicenter retrospective cohort study.
    Gynecol Oncol. 2020 May 26. pii: S0090-8258(20)31072.
    PubMed         Abstract available

  25. SILVA SR, Gaskins JT, Nichols MR, Metzinger DS, et al
    Cervical cancer incidence and mortality rates in Kentucky.
    Gynecol Oncol. 2020 May 23. pii: S0090-8258(20)31079.
    PubMed         Abstract available

    Health Psychol Rev

  26. MCBRIDE E, Tatar O, Rosberger Z, Rockliffe L, et al
    Emotional response to testing positive for human papillomavirus at cervical cancer screening: a mixed method systematic review with meta-analysis.
    Health Psychol Rev. 2020 May 24:1-35. doi: 10.1080/17437199.2020.1762106.
    PubMed         Abstract available

    HIV Med

  27. MUKANYANGEZI MF, Rugwizangoga B, Manzi O, Rulisa S, et al
    Persistence rate of cervical human papillomavirus infections and abnormal cytology in Rwanda.
    HIV Med. 2019;20:485-495.
    PubMed         Abstract available

    Int J Cancer

  28. SENGAYI-MUCHENGETI M, Joko-Fru WY, Miranda-Filho A, Egue M, et al
    Cervical cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index (HDI): A population-based registry study.
    Int J Cancer. 2020 May 25. doi: 10.1002/ijc.33120.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  29. ZHAO Y, Li M, Li Y, Lv Q, et al
    Evaluation of folate receptor-mediated tumor detection as a triage tool in cervical cancer screening.
    Int J Gynaecol Obstet. 2020 May 29. doi: 10.1002/ijgo.13245.
    PubMed         Abstract available

  30. PAINTER H, Erlinger A, Simon B, Morroni C, et al
    Impact of cervicitis on performance of cervical cancer screening using HRHPV testing and visual evaluation in women living with HIV in Botswana.
    Int J Gynaecol Obstet. 2020 May 25. doi: 10.1002/ijgo.13235.
    PubMed         Abstract available

    Int J Gynecol Cancer

  31. HWANG WY, Kim JH, Suh DH, Kim K, et al
    The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Int J Gynecol Cancer. 2020 May 28. pii: ijgc-2020-001271.
    PubMed         Abstract available

  32. BOGANI G, Ghezzi F, Chiva L, Gisone B, et al
    Patterns of recurrence after laparoscopic versus open abdominal radical hysterectomy in patients with cervical cancer: a propensity-matched analysis.
    Int J Gynecol Cancer. 2020 May 23. pii: ijgc-2020-001381.
    PubMed         Abstract available

  33. MAYADEV J, Nunes AT, Li M, Marcovitz M, et al
    CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.
    Int J Gynecol Cancer. 2020 May 23. pii: ijgc-2019-001135.
    PubMed         Abstract available

    Int J Health Geogr

  34. TRAORE M, Vallee J, Chauvin P
    Risk of late cervical cancer screening in the Paris region according to social deprivation and medical densities in daily visited neighborhoods.
    Int J Health Geogr. 2020;19:18.
    PubMed         Abstract available

    Int J STD AIDS

  35. SWEET K, Bosire C, Sanusi B, Sherrod CJ, et al
    Prevalence, incidence, and distribution of human papillomavirus types in female sex workers in Kenya.
    Int J STD AIDS. 2020;31:109-118.

    Iran J Public Health

  36. FARZANEHPOUR M, Muhammadnejad A, Akhavan S, Emami Razavi AN, et al
    P16INK4A Immunohistochemistry as a Gold Standard for Cervical Cancer and Precursor Lesions Screening.
    Iran J Public Health. 2020;49:312-322.
    PubMed         Abstract available

    J Biomol Struct Dyn

  37. ZUKIC S, Oljacic S, Nikolic K, Veljovic E, et al
    Quantitative Structure-Activity Relationships of xanthen-3-one and xanthen-1,8-dione derivatives and design of new compounds with enhanced antiproliferative activity on HeLa cervical cancer cells.
    J Biomol Struct Dyn. 2020 May 28:1-18. doi: 10.1080/07391102.2020.1775125.
    PubMed         Abstract available

    J Cancer Res Clin Oncol

  38. PEREIRA APL, Trugilo KP, Okuyama NCM, Sena MM, et al
    IL-10 c.-592C>A (rs1800872) polymorphism is associated with cervical cancer.
    J Cancer Res Clin Oncol. 2020 May 23. pii: 10.1007/s00432-020-03256.
    PubMed         Abstract available

    J Comput Assist Tomogr

  39. YAMADA I, Oshima N, Wakabayashi A, Miyasaka N, et al
    Diffusion-Tensor Imaging of Uterine Cervical Carcinoma: Correlation With Histopathologic Findings.
    J Comput Assist Tomogr. 2020;44:426-435.
    PubMed         Abstract available

  40. UNLU E, Virarkar M, Rao S, Sun J, et al
    Assessment of the Effectiveness of the Vaginal Contrast Media in Magnetic Resonance Imaging for Detection of Pelvic Pathologies: A Meta-analysis.
    J Comput Assist Tomogr. 2020;44:436-442.
    PubMed         Abstract available

    J Infect Dis

  41. WANG H, Ma Y, Li R, Chen X, et al
    Associations of cervicovaginal lactobacilli with high-risk HPV infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis.
    J Infect Dis. 2019 Jun 26. pii: 5523772. doi: 10.1093.
    PubMed         Abstract available

    Lancet Infect Dis

  42. WIELAND U, Kreuter A
    Anal cancer risk: HPV-based cervical screening programmes.
    Lancet Infect Dis. 2019 Jun 13. pii: S1473-3099(19)30296.

    Medicine (Baltimore)

  43. YANG S, Zhao J, Li L
    NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study.
    Medicine (Baltimore). 2020;99:e19941.
    PubMed         Abstract available

    Pract Radiat Oncol

  44. KISLING K, Cardenas C, Anderson BM, Zhang J, et al
    Automatic verification of beam apertures for cervical cancer radiotherapy.
    Pract Radiat Oncol. 2020 May 22. pii: S1879-8500(20)30111.
    PubMed         Abstract available

    Semin Radiat Oncol

  45. VU CC, Jawad MS, Krauss DJ
    The Cost-Effectiveness and Value Proposition of Brachytherapy.
    Semin Radiat Oncol. 2020;30:87-93.
    PubMed         Abstract available

    Turk J Pharm Sci

  46. BECIT M, Aydin S
    An In Vitro Study on the Interactions of Pycnogenol((R)) with Cisplatin in Human Cervical Cancer Cells.
    Turk J Pharm Sci. 2020;17:1-6.
    PubMed         Abstract available

    Zhonghua Fu Chan Ke Za Zhi

  47. ZHU YL, Zhang WH, Liu BB, Zhang P, et al
    [Preliminary study of the clinical value of colposcopy in diagnosing vagina invasion in cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2020;55:322-326.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.